Piper Sandler Upgrades Oscar Health to Overweight, Sees Strong Profit Potential
Piper Sandler upgrades Oscar Health to Overweight with a $25 price target, citing growth and profitability potential through 2027.
Piper Sandler upgrades Oscar Health to Overweight with a $25 price target, citing growth and profitability potential through 2027.
White House plans to unveil health policy framework extending ACA subsidies for two years while adding income caps and minimum premium requirements to address expiring benefits.
Health insurance stocks dropped during pre-market trading after President Trump criticized insurers on social media and proposed providing direct subsidies to consumers instead of ACA tax credits.
Oscar Health reports third quarter loss amid rising healthcare costs but plans return to profitability in 2026 through rate increases and market expansion in ACA insurance space.
Oscar Health's Q2 2025 showed a $228M loss due to sicker patients. CEO Mark Bertolini aims for 2026 profitability.